| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2883149 | The Annals of Thoracic Surgery | 2007 | 8 Pages |
Abstract
Chemoradiotherapy followed by surgery appears to be associated with the best survival and the largest expected gain in QALYs. However, the improvement in quality-adjusted life expectancy is modest at 40 days, and surgery alone becomes the preferred strategy if the reduction in utility associated with multimodality treatment is increased to 21%.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Andrew J. MD, MS, Fiona M. PhD, William A. MD, MPH, Braden J. MD, MS, Sean C. MD, MPH, Richard J. MD, Joanne MS,